1Gion M, Mione R, Leon AE, et al. Comparison of the diagnostic accuracy of CA27-2 and CA15-3 in primary breast cancer. Clin Chem. 1999, 45(5):630.
2Pinto MM. CA15-3 assay in effusions: comparison with carcinoembryonic antigen and CA15-3 assay and cytologic diagnosis. Acta Cytol. 1996, 40(3):437.
3Watanabe Netal. Serum C-erb B2 in breast cancer patient. Acta Oncol. 1994, 33(5):901.
4Al-Jarallah MA, Behbehani AE, el-Nass SA, et al. Serum CA15-3 and CEA patterns in postsurgical follow-up, and in monitoring clinical course of metastatic cancer in patients with breast carcinoma. Eur J Surg Oncol. 1993, 9(1):74.
5Cioffi M, Fratta M, De Lucia D. CEA, TPA and CA15-3 in breast cancer. Cancer Detect Prevent. 1993, 17(1):87.
5Abelev GI, Perova SD, Khramkova NI, et al. Production of embryonal alpha globulin by transplantable mouse hepatomas [J]. Transplantation, 1963.1:174.
6Tatarinov YS, Afanaseva AV, Parfenova LF. Formation of serum proteins in human ontogeny [J]. Fed Proc Transl Suppl, 1964. 23(1):437.
7Dudich I, Tokhtamysheva N, Semenkova L. et al. Isolation and structural and functional characterization of two stable pep tic fragments of human alpha fetoprotein [J]. Biochemistry, 1999.38(32) : 10406.
8Gillespie JR, Uversky VN. Structure and function of alpha-re toprotein: a biophysical overview [J]. Biochim Biophys Acta, 2000; 1480(1-2):41.
9Karamova ER, Yazova AK, Goussev AI, et al. Conformational variants of human alpha fetoprotein [J]. Tumour Biol, 1998; 19 (4) : 310.
10Bourreille J, Metayer P, Sauger F, et al. Existence of alpha feto protein during gastric origin secondary cancer of the liver [J]. Presse Med, 1970. 78(28):1277.
